HRQoL SF‐36: PCS units · people with pulmonary hypertension
1 finding from 1 review
HRQoL SF‐36: MCS units · people with pulmonary hypertension
1 finding from 1 review
Functional exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life · patients with chronic obstructive pulmonary disease
2 findings from 1 review
Inspiratory muscle strength · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
3 findings from 1 review
no estimate extracted
6 studies · 144 participants
Very low
no estimate extracted
8 studies · 238 participants
Very low
no estimate extracted
4 studies · 150 participants
Low
Health‐related quality of life · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
2778 participants
Low
Health status ‐ Dyspnoea · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
356 participants
Low
ED visits · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
1939 participants
Low
Anxiety and depression · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
1647 participants
Moderate
FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
1 finding from 1 review
Need for additional IV or oral antibiotics · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (moderate) · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
It is very uncertain whether summary of findings: Inhaled antibiotics plus IV antibiotics changes adverse events moderate adverse events experienced during and after… compared with IV antibiotics only (very low certainty).
1 finding from 1 review
Microbiology Emergence of resistant organisms · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
It is very uncertain whether summary of findings: Inhaled antibiotics plus IV antibiotics changes microbiology Emergence of resistant organisms compared with IV antibiotics only (very low certainty).
1 finding from 1 review
Quality of life: number of participants achieving MCID · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
Summary of findings: Inhaled antibiotics plus IV antibiotics showed no clear difference in quality of life: number of participants achieving MCID compared with IV antibiotics only (low certainty).
1 finding from 1 review
Time off school or work · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
2 findings from 1 review
Long‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in long‐term all‐cause mortality compared with inpatient treatment (low certainty).
1 finding from 1 review
Major bleeding · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in major bleeding compared with inpatient treatment (low certainty).
2 findings from 1 review
Minor bleeding · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in minor bleeding compared with inpatient treatment (low certainty).
1 finding from 1 review